Resonetics announced today that it has signed an agreement to acquire Resolution Medical, a leading provider of integrated design and manufacturing solutions for complex medical devices. Resolution ...
The FDA has approved the first prescription, at-home neuromodulation therapy for individuals with major depressive disorder ...
Medical Device Network on MSN
Boston Scientific touts long-term data of SCS therapy
At the recently concluded North American Neuromodulation Society annual meeting, Boston presented a total of 17 abstracts.
Resonetics is moving deeper into the neuromodulation and structural heart markets with its latest deal. The Nashua, NH-based ...
PARK CITY, Utah--(BUSINESS WIRE)--BlueWind Medical, Ltd., a leader in implantable Tibial Neuromodulation (iTNM) and developer of the Revi® System, a patient-centric solution for urge urinary ...
The wearable device delivers electrical impulses through a headset that can be administered by the patient at home under ...
With its expansion into St. Louis, Restore Brain continues its mission to broaden access to advanced psychiatric treatments ...
Abbott Park, Illinois Tuesday, January 27, 2026, 13:00 Hrs [IST] ...
The FDA has approved ProlivRx, the first prescription, home-based brain neuromodulation therapy, as an adjunctive treatment ...
Abbott’s neuromodulation systems can significantly reduce pain-related healthcare visits for people living with chronic pain, according to five-year data.
This approval represents a significant regulatory milestone, making Proliv™Rx the first and only at-home neuromodulation treatment with FDA labeling applicable to treatment refractory MDD patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results